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Background: To evaluate the antifungal activity of the red propolis hydroalcoholic extract (RPHE) against Candida 
albicans biofilms. 
Material and Methods: The minimum inhibitory and fungicidal concentrations (MIC and MFC) of the RPHE were 
determined by the microdilution technique. C. albicans biofilms were formed on the surface of resin specimens pre-
conditioned with artificial saliva (1h). The specimens (N=48) were equally divided according to the four solutions 
used for anti-biofilm evaluation (n=12 per group). After overnight incubation, biofilms were daily exposed (2x/day 
for 15 min) along 3 days with 3% RPHE, 0.12% chlorhexidine (CHX), 50,000 IU/mL nystatin (NYS) or saline 
(0.9% NaCl). Biofilms were analyzed regarding the number of viable microorganisms (CFU/mL), the metabolic 
activity (MTT assay) and the proportion of hyphae (optical microscopy). 
Results: The MIC and MFC of RPHE were respectively 0.29 mg/mL (0.03%) and 1.17 mg/mL (0.12%). There 
was no difference in the microorganisms’ viability (CFU/mL) among groups treated with RPHE (4.92×103), CHX 
(3.33×102) or NYS (6.8×104), being all of them different from NaCl (3.93×107) (p<0.05). The CHX (0.133) had 
the lowest metabolic activity (p<0.05), followed by RPHE (0.292) and NYS (0.302) (p>0.05). All experimental 
groups had a mean proportion of hyphae <10%, lower than NaCl (70%). 
Conclusions: RPHE has antifungal activity against C. albicans biofilms, suggesting its use for the biofilm control 
on denture surfaces.
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Introduction
Oral candidiasis is an opportunistic infection related to 
the excessive proliferation of Candida, as a result of the 
homeostatic imbalance of oral microbiota (1). In many 
cases, Candida infection is associated with the use of 
removable dentures, especially among denture wearers 
who are not able to maintain satisfactory hygiene of 
their prosthesis (2,3).
Denture cleaning solutions are frequently recommended 
for the treatment of such infections, associated or not 
with the use of local antifungals (3,4). The efficacy of 
antifungal agents has been proven by a systematic re-
view of the literature (5). Although the efficacy of den-
ture cleansing solutions is also proven in the literature, 
new alternatives remain in constant development (4). 
Moreover, the preventive effect of these solutions has 
been little explored in the literature (4).
In general, recurrence of denture stomatitis may occur 
due to discontinuation of antifungal therapy and micro-
bial resistance (6,7). Methods for cleaning prosthetic 
surfaces may reduce the accumulation of biofilm, but 
do not prevent recolonization (8). In addition, they may 
compromise the longevity of dentures by promoting sur-
face changes such as abrasion and increased roughness 
(9).
Natural products have promoted the search for therapeu-
tic possibilities that are biocompatible and accessible to 
the population in order to overcome these limitations 
(10,11). Red propolis, mainly formed by the botanical 
compounds extraction of Dalbergia ecastophyllum from 
Apis mellifera bees, presents phenolic compounds, espe-
cially flavonoids. These phytochemicals are associated 
with antifungal activity (12) and make this product a 
promising natural antimicrobial agent (13-15).
Red propolis extract has been shown to control the im-
balance of oral microbiota homeostasis by reducing the 
proliferation of Candida (16), as well as being a biocom-
patible substance compared to synthetic antimicrobials 
(17,18), which may have undesirable effects, such as 
microbial resistance (19).
Thus, there is a need to evaluate its antifungal activi-
ty, with the purpose of presenting an alternative for the 
treatment of fungal infections. Therefore, the aim of this 
study was to evaluate the antifungal activity of the red 
propolis hydroalcoholic extract (RPHE) against C. albi-




This study did not involve human participants or mate-
rial collected from human (i.e.: saliva). Biofilms were 
developed in the presence of artificial saliva. Microor-
ganisms samples used in this study were derived from 
standardized strains cultured in laboratory.
-Red Propolis Hydroalcoholic Extract
The red propolis hydroalcoholic extract (RPHE) was ob-
tained in the concentration of 30%, provided by Apiário 
Edimel located in the town of João Pessoa, Brazil (Lati-
tude 7° 3′ 25,756′’; Longitude O 34° 50′ 55,155′’). Red 
propolis was collected within the Brazilian spring period 
(23º - 30º) (18). The RPHE was used in its commercial 
presentation (30% w/v, or 300 mg/mL) for the determi-
nation of Minimum Inhibitory Concentration (MIC). For 
anti-biofilm assays, the RPHE concentration was based 
on MIC and on a 10× dilution of its commercial form. 
-Standardization of Inoculum
Candida albicans (ATCC 90028) was reactivated in Pe-
tri dishes (AlamarTM, Diadema, BRA) containing Sabou-
raud Dextrose agar (Himedia LaboratoriesTM, Mumbai, 
India) and incubated at 37 °C for 48 hours. The inoculum 
was standardized in RPMI 1640 (Aldrich Chemical Co., 
St. Louis, USA) using a spectrophotometer (Lgi Scienti-
ficTM, São Paulo, BRA).  An optical density of 0.1, under 
600 nm wavelength, was set to obtain the concentration 
of 5×106 CFU/mL (20). The final concentration of the 
inoculum for MIC and biofilm assays were 5×103 and 
1×105 CFU/mL, respectively.
-Antifungal Activity
The antifungal activity was determined by means of the 
minimum inhibitory concentration (MIC), in which a 
microdilution assay was carried out in a 96-well microti-
ter plate (AlamarTM, Diadema, São Paulo, BRA), accor-
ding to M27A3 from CLSI (20). RPHE (30% w/v) and 
0.12% chlorhexidine (used as control) were diluted and 
then 100 μL of the inoculum was inserted into all wells, 
except in the line corresponding to the sterility control. 
Final concentrations ranged from 75 to 0.0366 mg/mL 
for RPHE and from 0.3 to 0.000146 mg/mL for CHX.
After the incubation period in aerobiosis (24 h at 37 ºC), 
the MIC corresponded to the last dilution of the RPHE in 
which the presence of microbial precipitate or turbidity 
in the culture medium after the incubation period was 
not verified. The determination of MIC was confirmed 
by the use of 3 mM Resazurin (Sigma, ST. Louis, MO, 
USA). Resazurin is a colorimetric indicator of cellular 
respiration, which when in blue represents a state of oxi-
dation and becomes pink when reduced by viable cells 
detection without the use of a spectrophotometer (21). 
After incubation for 4 h, the results were visualized by 
the visual method.
The minimum fungicidal concentration (MFC) was ob-
tained by seeding of 50 μL aliquots of dilutions equal to 
or greater than MIC. Then, Sabouraud Dextrose plates 
incubated with MIC aliquots were incubated at 37 °C for 
24h. The MFC was considered the lowest concentration 
of the substance that prevented the visible growth of the 
subculture, or the formation of up to three Colony For-
ming Units (CFU) (22). The tests for determination of 
MIC and MFC were performed in triplicate.
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-Anti-biofilm Activity
Anti-biofilm activity was evaluated after developing 
biofilms on the surface of denture base material. Resin 
specimens made of polymethylmethacrylate (PMMA) 
(QC-20, Dentsply Int IncTM, Weybridge, UK) were obtai-
ned from prefabricated stainless-steel molds of circular 
shape (10 mm diameter, 2 mm thickness). The resin was 
handled according to the manufacturer’s recommenda-
tions and inserted from the stainless-steel molds, using 
a pressure of 1000 N. Polymerization was by immersion 
in boiling water for 20 min, followed by slow cooling. 
The specimens were kept in distilled water to release 
residual monomer for 48h. The selection of specimens 
occurred after polishing with silicon carbide sandpaper 
in #400 and #600 granulation. Specimens that presen-
ted blisters or roughness were discarded. The specimens 
(N=48) were autoclaved (121°C, 15 min) immersed in 
distilled water solution. Then, they were equally divided 
according to the four solutions used for anti-biofilm eva-
luation (n=12 per group).
Prior to biofilm formation, the specimens were submi-
tted to the formation of artificial salivary pellicle (23), 
with 1% carboxymethyl, 0.0084% sodium chloride, 
0.12% potassium chloride, 0.0342% phosphate monoba-
sic potassium, 0.0146% calcium chloride, and 0.0052% 
magnesium chloride. Specimens were then incubated 
at 37°C for 2 h, in 24-well polystyrene culture plates 
(model K12-024, KasviTM, São José do Pinhais, BRA). 
After saliva removal, 2 mL of the C. albicans inoculum 
was inserted. The specimens were then incubated in the 
presence of the inoculum at 37 °C for 24 h.
After this period, the specimens were individually 
submitted to treatment (specimen’s immersion, 2 mL) 
with one of the antimicrobial solutions evaluated in this 
study: 3% RPHE (based on MIC and on a 10× dilution 
of RPHE’s commercial presentation), 0.12% Chlorhexi-
dine (CHX), 50,000 IU/mL Nystatin (NYS) and 0.9% 
Sodium Chloride (NaCl). The treatments were perfor-
med twice a day (8:00 am and 4:00 pm) for 3 days, du-
ring 15 min. After exposure to the solutions, the speci-
mens were washed in saline solution (2×) and the culture 
medium was renewed.
After 72 h, specimens were individually transferred to 
microtubes containing 1 mL saline. Specimens were 
then vortexed during 1 min for biofilm disruption. Ali-
quots of suspended cells were used for quantification of 
viable microorganisms, hyphae quantification and asses-
sing the metabolic activity.
For quantification of number of viable microorganisms, the 
suspension of cells were serially diluted (10-1 to 10-6) and 
10 μl aliquots were seeded (triplicate) on Sabouraud Dex-
trose agar and incubated at 37 °C for 48 h. After this period, 
the count of colony forming units (CFU/mL) was verified.
The suspension of cells was also analyzed under an op-
tical microscope using a 100× objective (Carl ZeissTM, 
Oberkochen, DEU), in order to determine the proportion 
of hyphae. For this purpose, each slide containing bio-
film precipitate was analyzed in at least three different 
points.
Metabolic activity was assessed by the soluble MTT 
assay 3-[(4,5-dimethylthiazol-2-yl) -2,5-diphenylte-
trazolium bromide] as described by Loures and Levitz 
(2015) (24), with modifications. The suspended cells 
from the biofilms were centrifuged for 5 min (CientecTM, 
Belo Horizonte, BRA). After that, the supernatant was 
eliminated and 500 μL of MTT solution was added to 
microtubes, followed by incubation (37 °C, 4 h), without 
exposure to light. The microtubes were then centrifuged 
again (5 min) to remove the supernatant. After that, the 
precipitated was treated with acid alcohol (350 μL) and 
absorbance was read in a spectrophotometer (490 nm).
-Data Analysis
The results of MIC, MFC and hyphae ratio were tabu-
lated using Microsoft Office Excel 2007TM and analyzed 
descriptively. SPSS software version 20.0 (IBMTM, Chi-
cago, USA) was used considering a 5% significance 
level. The non-normal distribution was verified by the 
Shapiro-Wilk test. The Kruskal-Wallis and Mann-Whit-
ney tests were used to evaluate the number of viable mi-
croorganisms and metabolic activity.
Results
The MIC and MFC of the RPHE were respectively 0.29 
mg/mL (0.03%) and 1.17 mg/mL (0.12%). The CHX 
0.12% showed fungicidal action in all concentrations 
tested. Sterility and growth controls indicated, respec-
tively, absence of culture medium contamination and 
viability of the strains tested.
There was no statistically significant difference 
(p>0.05) for the number of viable cells among RPHE 
(4.92×103 CFU/mL), CHX (3.33×102 CFU/mL) and 
NYS (6,8×104 CFU/mL), although those differed from 
control (3.93×107 CFU/mL) (p<0.05) (Fig. 1). Control 
group biofilm (NaCl) presented 70% hyphae, whilst the 
groups exposed to RPHE, CHX and NYS presented less 
than 10% (Fig. 2).
Compared to control (100%), the lowest metabolic 
activity was observed in the group exposed to CHX 
(22.23%) (p<0.05). RPHE (48.82%) and NYS (50.43%) 
also reduced the metabolic activity and differed signifi-
cantly from control and CHX (p<0.05) (Fig. 3).
Discussion
The present study demonstrated that the red propolis hy-
droalcoholic extract inhibited the activity of C. albicans, 
in its planktonic and biofilm form. The RPHE activity 
was considered satisfactory (0.29 mg/mL), since exce-
llent MIC values for natural products were found below 
0.1 mg/mL (25). A previous study confirmed the anti-
microbial activity of other red propolis extract against 
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Fig. 1: Fungal viability (Log10UFC/mL) in biofilms after treatments. Different letters indicate statisti-
cally significant differences between the groups (p<0.05, Kruskal-Wallis and Mann-Whitney).
Fig. 2: Proportion of hyphae in relation to the quantitative of yeasts 
in biofilms after treatments. Photomicrography of C. albicans bio-
films after the end of the experimental protocol to the test products, 
at 1000× magnification. A = RPHE, B = CHX, C = NYS and D = 
NaCl. The asterisk (*) represents yeast structures and the arrow rep-
resents filamentous structures (hyphae).
Candida resistant to fluconazole (19), suggesting that 
the propolis extract could be a promising antimicrobial 
agent. Results of present study corroborate with this pre-
vious finding (19) and added more evidence about the 
therapeutic potential of a RPHE against Candida infec-
tions. According to our data, the RPHE reduced the pro-
liferation of viable microorganisms and also decreased 
the presence of hyphae within the Candida biofilm.
The RPHE evaluated in the present study is commercia-
lly available from the apiary at a concentration of 30%. 
The anti-biofilm assays were performed at 3% concen-
tration, corresponding to MIC×100 and to 10× dilution 
of its commercial presentation. The increased concen-
tration of RPHE (compared to MIC) is due to the robust 
structure of biofilms, which may influence the resistance 
compared to planktonic cells (26).
Although there is no consensus attesting to the efficacy 
of natural products in the treatment of fungal infections 
(27), indiscriminate use may result in changes that affect 
application safety (28). On the other hand, the RPHE 
can be considered promising since the results found for 
the metabolic activity were similar to nystatin. In ad-
dition, the same RPHE (3%) was evaluated in another 
study that considered acceptable its use in cytotoxicity 
in cells of fibroblasts (L-929), as their use for 1 minute 
was able to maintain 43% viable cells (18).
The low cytotoxicity demonstrated by RPHE does not im-
pair its recommendation as a mouthwash or denture clean-
ser (18). The biofilm model in this study validates its effect 
for decontamination of dental prostheses, without contact 
with the oral mucosa. It is still necessary to carry out new 
studies using different concentrations of the product and 
with a longer exposure time to evaluate the effect on the 
color change on the surfaces of dental prostheses (29).
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Fig. 3: Metabolic activity after the MTT test. Different letters indicate statistically significant differ-
ences between the groups (p<0.05, Kruskal-Wallis and Mann-Whitney).
Red propolis and nystatin reduced the metabolic activity 
at controlled levels of cell proliferation, indicating that 
those substances have potential for biofilm inhibition. 
Possibly this similar action between RPHE and nysta-
tin is due to the lower concentration used in the present 
study, since at 100,000 IU nystatin can cause an increase 
in roughness and loss of resin hardness when used in up 
to 15 days (30). The biofilm control through inhibition 
of cell proliferation is considered effective against oral 
infections (4,6). All treatment substances evaluated in 
the present study reduced the number of hyphae present 
in this biofilm, therefore affecting the complexity and 
virulence of this microbial community (7).
This in vitro study suggests that red propolis extract 
should be further investigated so that it can be used 
on disinfection of removable dentures. The number of 
specimens per group in this study is in accordance with 
previous investigations (8,18). However, larger sample 
size is strongly recommended for confirming results. In 
addition, treatment duration is an aspect that should be 
improved in future investigations. The number of treat-
ment expositions per day, the duration of expositions 
and the number of days under treatment can be modified 
in order to simulate clinical use of the RPHE as a den-
ture cleanser.
Therefore, this study stimulates further investigations that 
could validate the clinical use of RPHE. Conventional 
cleansing agents can influence the microbial resistance 
and promote surface alterations, such as abrasion and the 
roughness, that decrease the longevity of dentures (1,9). 
Although we did not evaluate the effects of these treat-
ments on the mechanical properties of PMMA resin, we 
observed that RPHE could be indicated as an effective 
cleansing agent for the control of Candida biofilms.
Conclusions
The red propolis hydroalcoholic extract has antifungal 
activity against C. albicans biofilms, suggesting its use 
for the control of denture biofilms.
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